Generics 10

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lisdexamfetamine manufacturers

10 products found

Filters

10 products found

lisdexamfetamine

Oral suspension 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #8593
It is a private R&D and business development organization established in the 2000s, specializing in the design and development of new pharmaceutical products worldwide. They have an average of 5-6 new developments per year, an average of 8-10 DCPs per year, more than 60 dossier updates in the last 10 years, they have more than 3 valid and approved patent applications, and approximately 140 MAs worldwide.

Manufacturer usually replies in 2 days

lisdexamfetamine

Oral solution 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15507

A privately owned CDMA service provider that is aimed to benefit people from its pharmaceutical solutions. They have dosages in the form of oral liquid and likewise. The company is one of the pioneers of having high-value credentials in the development, manufacturing, and commercialization of healthcare products.

Manufacturer usually replies in 8 days

lisdexamfetamine

Oral solution 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
EU MA's Running
Manufacturer #21467

Manufacturer usually replies in 9 days

lisdexamfetamine

Capsules, hard liquid 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Spain
Comments
EU MA’s Granted
Manufacturer #21467

Manufacturer usually replies in 9 days

lisdexamfetamine

Capsules 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Vyvanse
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 6 days

lisdexamfetamine

Capsules 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Comments
Dossier availability date: Q1 2025
Manufacturer #10620
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, the Middle East, North America, LATAM, and Asia for 50+ years. The main therapeutic areas include cardiovascular, rheumatology, nephrology, and central nervous system. The main dosage forms are oral solid and multi-dose powder. They are produced in GMP-compliant manufacture.

Manufacturer usually replies in 14 days

lisdexamfetamine

Capsules 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915

Manufacturer usually replies in 14 days

lisdexamfetamine

Capsules 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 9 days

lisdexamfetamine

Capsules 30 mg, 50 mg, 70 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #13510
It was established in the 2010s. It creates and sells biotech products developed with natural product extracts, helping to improve your heart health, immune system, or mood. It offers the pharmaceutical and nutraceutical industry a natural, science-based therapeutic alternative that can be safely used either in combination with existing medications as add-on ingredients for improved efficacy or presented as a single standing remedy; with patented products, proven benefits, and claims for our natural ingredients in the areas of for example mood improvement, anxiety and stress reduction, eye-health, cardiovascular health advancement and enhancement of the body´s immune system against cold and flu.

Manufacturer usually replies in 6 days

lisdexamfetamine

Capsules 20 mg, 30 mg, 50 mg, 70 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #32970